AstraZeneca CEO Says Europe Prices Should Be Higher, U.S. Lower
814 views · Published 8 November 2018 · 2:41 · Indexed 10 November 2026
Channel: Bloomberg Television · 2018 · News & Politics
Nov.08 -- AstraZeneca Plc Chief Executive Officer Pascal Soriot discusses drug pricing and Brexit preparations after the Cambridge, England-based company reported profit which beat analysts’ estimates. AstraZeneca's stock is the best performer among major European drugmakers since the start of the year. Soriot speaks with Bloomberg's Guy Johnson on "Bloomberg Surveillance."
More from this channel
-
2:16
Economic Policy Institute's Bivens Says Criticism of Tariffs Is Warranted
-
3:02
Blanchflower Says Raising Rates 'Is a Fundamental Mistake'
-
2:57
BlackRock's Rieder Says It's a Risk-Off Environment
-
2:04
How Weather Impacted U.S. Job Creation in March
-
2:32
Millennials Are Finding Jobs, Just Not the Ones They Want
-
1:06
Powell Says Gradual Rate Hikes Best Promote the Fed's Goals
-
0:58
Powell Says Wage Growth Shows Job Market Not 'Excessively Tight'
-
2:17
Quad Capital's Borish Sees More Whiplash in Markets